Prognostic and predictive value of supradiaphragmatic lymph node involvement detected by 18F-FDG PET/CT in advanced ovarian cancer: a systematic review and meta-analysis
Archives of Gynecology and Obstetrics · 2025
DOI: 10.1007/s00404-025-08234-w ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Gynecology and Obstetrics, 2025. Verfasst von Christian Braun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Lucerne Cantonal Hospital - Women's Hospital, Spitalstrasse 16, 6000, Lucerne, Switzerland. christian.braun@luks.…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Ovarian Neoplasms, Lymphatic Metastasis, Carcinoma, Ovarian Epithelial. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Luzern.
Abstract (Originalsprache)
Objective
To evaluate the prognostic and predictive significance of supradiaphragmatic lymph node (SDLN) positivity detected by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Methods
A systematic review and meta-analysis was conducted according to PRISMA 2020 guidelines and registered with PROSPERO. Studies reporting on overall survival (OS), progression-free survival (PFS), and complete cytoreduction (R0) in patients with and without 18F-FDG PET/CT-detected SDLN metastases were identified through comprehensive database searches conducted on December 18, 2024. Data from five retrospective, single-center studies comprising a total of 605 patients were included in the quantitative synthesis. Meta-analyses were performed using a random-effects model.
Results
SDLN positivity on 18F-FDG PET/CT was significantly associated with worse survival outcomes and lower resection rates. The pooled hazard ratio (HR) for OS was 1.60 (95% CI 1.19–2.25, p = 0.002) and for PFS 1.53 (95% CI 1.19–1.96; p = 0.0009), indicating poorer prognosis in SDLN-positive patients. The odds of achieving complete cytoreduction were significantly reduced in this group (OR = 0.32, 95% CI 0.15–0.68, p = 0.003). While heterogeneity was low for progression-free and overall survival ( I 2 = 0%), moderate heterogeneity was observed in the analysis of complete cytoreduction ( I 2 = 54%). None of the included studies provided histologic confirmation of 18F-FDG PET/CT-positive SDLNs.
Conclusions
18F-FDG PET/CT-detected SDLN positivity is associated with worse survival and lower resectability in advanced ovarian cancer. Due to lacking histologic confirmation and retrospective data, prospective validation is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Lucerne Cantonal Hospital - Women's Hospital, Spitalstrasse 16, 6000, Lucerne, Switzerland. christian.braun@luks.ch.
- Department of Gynecologic Oncology, Lucerne Cantonal Hospital - Women's Hospital, Spitalstrasse 16, 6000, Lucerne, Switzerland.
Förderung
- University of Luzern
Zitieren
APA
Braun, C., Peikert, J., & Brambs, C. (2025). Prognostic and predictive value of supradiaphragmatic lymph node involvement detected by 18F-FDG PET/CT in advanced ovarian cancer: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-025-08234-w
Vancouver
Braun C, Peikert J, Brambs C. Prognostic and predictive value of supradiaphragmatic lymph node involvement detected by 18F-FDG PET/CT in advanced ovarian cancer: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. 2025. doi:10.1007/s00404-025-08234-w
BibTeX
@article{Braun2025,
author = {Braun, Christian and Peikert, Julia and Brambs, Christine},
title = {Prognostic and predictive value of supradiaphragmatic lymph node involvement detected by 18F-FDG PET/CT in advanced ovarian cancer: a systematic review and meta-analysis},
journal = {Archives of Gynecology and Obstetrics},
year = {2025},
doi = {10.1007/s00404-025-08234-w}
}
EUVIMED